Article
19 Mar 2026
Le CEPMB lance une consultation sur le projet de directives relatives à la pratique pour les audiences
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
17 Mar 2026
PMPRB Launches Consultation On Proposed Practice Directions For Hearings
Article
12 Feb 2026
AI Scribes And Privacy Risks: Balancing Convenience, Patient Rights, And Legal Obligations
Article
06 Feb 2026
Preventing Confidentiality Incidents: New CAI Guidance
Article
29 Jan 2026
OSFI E-23 Guideline And Its Impact On Financial Institutions
Article
21 Jan 2026
Le CRTC Adopte Une Approche De L'IA Privilégiant L'humain Pour La Certification Du Contenu Canadien
Article
15 Jan 2026
CRTC Signals Human-First Approach To AI In Canadian Content Certification
Article
29 Dec 2025
Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes
Article
23 Dec 2025
Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma
Article
01 Dec 2025
Open Banking 2025: Read, Write, And Rewrite The Rules
Article
25 Nov 2025
Move It, Move It: Amendments To PIPEDA Add Data Mobility
Article
21 Nov 2025
Dealing A New Hand: Federal Court Gives Card Game Patent A Second Chance
Article
13 Nov 2025
Le Budget 2025 comprend des incitatifs fiscaux pour promouvoir l'investissement et l'innovation au Canada
Article
12 Nov 2025
Budget 2025 Maintains Momentum In Financial Services Industry Reform
Article
12 Nov 2025
Ctrl+Alt+Bank: Canada Reboots Open Banking With Budget 2025
Article
11 Nov 2025
Budget 2025 Includes Tax Incentives To Promote Investment And Innovation In Canada
Article
10 Nov 2025
Budget 2025 Proposes To Introduce Federal Stablecoin Legislation
Article
07 Nov 2025
Projet de loi C-8 : Ce que les exploitants de cybersystèmes essentiels doivent savoir pour renforcer leur cybersécurité
Article
06 Nov 2025
Streamlined Biosimilar Approvals: What The End Of Biosimilar Phase III Trials Means For Innovative Pharmaceutical Patent Holders
Article
29 Oct 2025
AMF v. Gagnon: The First 'Ripple' In The CSA's Jurisdiction Over Crypto Assets